Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract

<b>Background/Objectives:</b> This study aims to gain insights into the antimicrobial and antiherpetic activity of hyperforin-rich <i>Hypericum perforatum</i> L. (HP) extract using nanostructured lipid carriers (NLCs) as delivery platforms. <b>Methods</b>: Two established NLC specimens, comprising glyceryl behenate and almond oil or borage oil, and their extract-loaded counterparts (HP-NLCs) were utilized. Their minimal bactericidal/fungicidal concentrations (MBC; MFC) were investigated against <i>Escherichia coli</i> ATCC 25922, <i>Staphylococcus aureus</i> ATCC 25923, <i>Pseudomonas aeruginosa</i> ATCC 10145, <i>Klebsiella pneumoniae</i> ATCC 10031, and <i>Candida albicans</i> ATCC 10231. The anti-herpesvirus (HSV-1) potential was evaluated concerning antiviral and virucidal activity and impact on viral adsorption. <b>Results</b>: The borage oil-based extract-loaded nanodispersion (HP-NLC2) exhibited pronounced microbicidal activity against <i>S. aureus</i> (MBC 6.3 mg/mL), <i>K. pneumoniae</i> (MBC 97.7 µg/mL), and <i>C. albicans</i> (MFC < 48.8 µg/mL), unlike the almond oil-containing sample (HP-NLC1), which showed only weak inhibition of the fungal growth. HP-NLC2 was found to be less cytotoxic and to suppress HSV-1 replication slightly more than HP-NLC1, but generally, the effects were weak. Neither the empty lipid nanoparticles nor the HP extract-loaded carriers expressed activity against <i>E. coli</i>, <i>P. aeruginosa</i>, the HSV-1 extracellular virions, or viral adhesion. <b>Conclusions</b>: It could be concluded that both HP-NLC samples revealed only minor antiherpetic potential of the hyperforin-rich extract, but HP-NLC2 demonstrated significant antibacterial and antimycotic activity. Therefore, the latter was featured as a more convenient HP-carrier system for nano-designed dermal pharmaceutical formulations. Such a thorough investigation of hyperforin-determined anti-HSV-1 effects and antibacterial and antimycotic properties, being the first of its kind, contributes to the fundamental knowledge of HP and reveals new perspectives for the utilization, limitations, and therapeutic designation of its non-polar components.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2025-03-04
DOI
https://doi.org/10.3390/ph18030366
Citations
4
Primary Topic
Natural Compound Pharmacology Studies
Type
article
Field-Weighted Citation Impact
7.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract

Velichka Andonova, Nadezhda Ivanova, Viliana Gugleva, Metodi Metodiev et al.
4 citations
Pharmaceuticals
Natural Compound Pharmacology Studies
7.00
article

Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract

Velichka Andonova, Nadezhda Ivanova, Viliana Gugleva, Metodi Metodiev, Neli Ermenlieva, Yoana Sotirova, Neli Vilhelmova-Ilieva, Lora Simeonova
article en
4 citations

Abstract

<b>Background/Objectives:</b> This study aims to gain insights into the antimicrobial and antiherpetic activity of hyperforin-rich <i>Hypericum perforatum</i> L. (HP) extract using nanostructured lipid carriers (NLCs) as delivery platforms. <b>Methods</b>: Two established NLC specimens, comprising glyceryl behenate and almond oil or borage oil, and their extract-loaded counterparts (HP-NLCs) were utilized. Their minimal bactericidal/fungicidal concentrations (MBC; MFC) were investigated against <i>Escherichia coli</i> ATCC 25922, <i>Staphylococcus aureus</i> ATCC 25923, <i>Pseudomonas aeruginosa</i> ATCC 10145, <i>Klebsiella pneumoniae</i> ATCC 10031, and <i>Candida albicans</i> ATCC 10231. The anti-herpesvirus (HSV-1) potential was evaluated concerning antiviral and virucidal activity and impact on viral adsorption. <b>Results</b>: The borage oil-based extract-loaded nanodispersion (HP-NLC2) exhibited pronounced microbicidal activity against <i>S. aureus</i> (MBC 6.3 mg/mL), <i>K. pneumoniae</i> (MBC 97.7 µg/mL), and <i>C. albicans</i> (MFC < 48.8 µg/mL), unlike the almond oil-containing sample (HP-NLC1), which showed only weak inhibition of the fungal growth. HP-NLC2 was found to be less cytotoxic and to suppress HSV-1 replication slightly more than HP-NLC1, but generally, the effects were weak. Neither the empty lipid nanoparticles nor the HP extract-loaded carriers expressed activity against <i>E. coli</i>, <i>P. aeruginosa</i>, the HSV-1 extracellular virions, or viral adhesion. <b>Conclusions</b>: It could be concluded that both HP-NLC samples revealed only minor antiherpetic potential of the hyperforin-rich extract, but HP-NLC2 demonstrated significant antibacterial and antimycotic activity. Therefore, the latter was featured as a more convenient HP-carrier system for nano-designed dermal pharmaceutical formulations. Such a thorough investigation of hyperforin-determined anti-HSV-1 effects and antibacterial and antimycotic properties, being the first of its kind, contributes to the fundamental knowledge of HP and reveals new perspectives for the utilization, limitations, and therapeutic designation of its non-polar components.

PharmaceuticalsVol. 18(3)
Medical University of Varna (BG), Bulgarian Academy of Sciences (BG), Stephan Angeloff Institute of Microbiology (BG)
Openalex Percentile: Top 4%
Natural Compound Pharmacology Studies
7.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.